Diurnal Variation of Maximal Fat Oxidation in metabolic syndrome patients
- Disease/Condition
- Nutritional, Metabolic, Endocrine
- Primary sponsor
- Sahloul university hospital Department of biochemistry
- Funder
- Biochemistry Department Sahloul University Hospital
- Location
- Tunisia
- Phase
- Phase 2
- Start date
- Jun 28, 2023
- End date
- Apr 28, 2023
Insulin resistance states, such as type 2 diabetes mellitus and metabolic syndrome (MetS), are characterized by mitochondrial dysfunction (MitoD) and poor capacity to oxidize fat. Furthermore, those patients with T2DM and MetS are overly reliant on Carbohydrates derived energy sources and possess limited ability to transition between Carbohydrate oxidation and FAT both at rest and during exercise, a state commonly known as metabolic inflexibility. In human adipocytes, genes implicated in fatty acid metabolism show transcriptomic rhythmicity, indicating lipid homeostasis is under circadian control. Several lines of evidence suggest that metabolic genes are directly under control of the clock machinery. In line with this transcriptomic data, it has been demonstrated that maximal fat oxidation (MFO) and the intensity at which MFO occurs is higher in the afternoon than in the morning in non-athlete male students in untrained normal-weight, athletes and obese individuals, but not in young health women. This is particularly interesting in the context of weight loss programs because timing exercise to the afternoon period may result in greater weight loss. Therefore, this study aims to evaluate whether there are diurnal variations in maximal fat oxidation in metabolic syndrome patients.
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR202306776991260
- Type
- Non-Device Trial
Access comprehensive clinical trial information for PACTR202306776991260 through Pure Global AI's free database. This Phase 2 trial is sponsored by Sahloul university hospital Department of biochemistry and is currently Recruiting. The study focuses on Nutritional, Metabolic, Endocrine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.